sponsored
PatientsVille.com Logo

PatientsVille

Soma Off Label Use Side Effects

Soma Off Label Use Side Effect Reports


The following Soma Off Label Use side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Off Label Use, can occur, and what you can do about them.

A side effect could appear soon after you start Soma or it might take time to develop.



Neoplasm Progression, Off Label Use

This Off Label Use side effect was reported by a physician from FR. A 13-year-old female patient (weight:NA) experienced the following symptoms/conditions: silver-russell syndrome. The patient was prescribed Somatropin (dosage: NA), which was started on 2011. Concurrently used drugs: NA. When starting to take Somatropin the consumer reported the following symptoms:
  • Neoplasm Progression
  • Off Label Use
These side effects may potentially be related to Somatropin.
Pancreatitis Acute, Condition Aggravated, Off Label Use, Blood Pressure Systolic Increased

This Off Label Use Somatuline L.p. side effect was reported by a consumer or non-health professional from FR on Jul 09, 2013. A male , 32 years of age, was diagnosed with and was treated with Somatuline L.p.. The patient presented the following health conditions:
  • Pancreatitis Acute
  • Condition Aggravated
  • Off Label Use
  • Blood Pressure Systolic Increased
. Somatuline L.p. dosage: (90mg, 1 In 4 Wk), Subcutaneous. Additional drugs used at the same time:
  • Creon (pancreatin)
  • Tramadol (tramadol)
The patient was hospitalized.
Hepatic Cyst Infection, Escherichia Sepsis, Abdominal Pain, Off Label Use, Hepatomegaly

This is a Somatuline side effect report of a 50-year-old female patient (weight:NA) from NL, suffering from the following symptoms/conditions: congenital cystic kidney disease, who was treated with Somatuline (dosage:NA, start time: NS), combined with:
  • Amlodipine (amlodipine)
, and developed a serious reaction and a Off Label Use side effect. The patient presented with:
  • Hepatic Cyst Infection
  • Escherichia Sepsis
  • Abdominal Pain
  • Off Label Use
  • Hepatomegaly
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatuline treatment in female patients suffering from congenital cystic kidney disease, resulting in Off Label Use.

Anaphylactic Reaction, Obstructive Airways Disorder, Pharyngeal Oedema, Swollen Tongue, Off Label Use

A 42-year-old female patient (weight: NA) from GB with the following symptoms: diarrhoea,off label use started Somatuline Autogel treatment (dosage: NA) on Feb 20, 2013. Soon after starting Somatuline Autogel treatment, the consumer experienced several side effects, including:
  • Anaphylactic Reaction
  • Obstructive Airways Disorder
  • Pharyngeal Oedema
  • Swollen Tongue
  • Off Label Use
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Somatuline Autogel side effects, such as Off Label Use.
Off Label Use, Nausea, Asthenia, Dyspnoea

A female patient from US was prescribed and started Somavert on Nov 05, 2012. Patient felt the following Soma side effects: off label use, nausea, asthenia, dyspnoea Additional patient health information: Female , 67 years of age, The consumer reported the following symptoms: was diagnosed with and. Somavert dosage: 10 Mg, 1x/day. Concurrently used drugs: NA.
Off Label Use

This report suggests a potential Somavert Off Label Use side effect(s) that can have serious consequences. A 58-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): acromegaly,pituitary adenoma and used Somavert (dosage: Unk) starting NS. Soon after starting Somavert the patient began experiencing various side effects, including:
  • Off Label Use
Drugs used concurrently:NA. Although Somavert demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Off Label Use, may still occur.
Emotional Distress, Arteriospasm Coronary, Chest Pain, Off Label Use

An adverse event was reported by a health professional on May 23, 2012 by a male taking Somatuline Depot (dosage: 120 Mg (120 Mg, 1 In 28 D), Intramuscular) was diagnosed with and. Location: NETHERLANDS , 55 years of age, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Soma side effects: emotional distress, arteriospasm coronary, chest pain, off label use. Additional medications/treatments: The patient was hospitalized.
Injection Site Haemorrhage, Dysphemia, Confusional State, Condition Aggravated, Blood Glucose Decreased, Off Label Use, Abnormal Behaviour

This Off Label Use problem was reported by a health professional from UNITED STATES. A 23-year-old patient (weight: NA) was diagnosed with the following medical condition(s): off label use,hypoglycaemia.On Feb 01, 2010 a consumer started treatment with Somatuline Depot (dosage: 120 Mg, Once Every 30 To 35 Days (120 Mg, Once Every 30 To 35 Days), Subcutaneous). The following drugs/medications were being taken at the same time: NA. When commencing Somatuline Depot, the patient experienced the following unwanted symptoms /side effects:
  • Injection Site Haemorrhage
  • Dysphemia
  • Confusional State
  • Condition Aggravated
  • Blood Glucose Decreased
  • Off Label Use
  • Abnormal Behaviour
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Off Label Use, may become evident only after a product is in use by the general population.
Gait Disturbance, Off Label Use, Procedural Pain, Lymphoedema, Fall, Septic Arthritis Staphylococcal, Arthralgia

This is a Soma side effect report of a female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Soma (dosage: Unk) starting Apr 29, 2009. Concurrently used drugs:
  • Naprosyn
  • Sodium Chloride (10 Ml, Single)
  • Vicodin
  • Ambien
  • Buspirone Hcl (Unk)
  • Magnevist (1 Ml, Single)
  • Magnevist
  • Lidocaine (5 Ml, Single)
Soon after that, the consumer experienced the following of symptoms:
  • Gait Disturbance
  • Off Label Use
  • Procedural Pain
  • Lymphoedema
  • Fall
  • Septic Arthritis Staphylococcal
  • Arthralgia
The patient was hospitalized. This opens a possibility that Soma could cause Off Label Use and that some female patients may be more susceptible.
Off Label Use, Urinary Tract Infection

This Off Label Use side effect was reported by a health professional from NETHERLANDS on Dec 01, 2011. A female patient from NETHERLANDS , 35 years of age, was diagnosed with and was treated with Somatuline Depot. Directly after treatment started, patient experienced the unwanted or unexpected Soma side effects: off label use, urinary tract infection. Somatuline Depot dosage: 120 Mg (120 Mg, 1 In 28 D), Intramuscular. The patient was hospitalized. These side effects may potentially be related to Somatuline Depot.
Off Label Use, Insomnia

This Off Label Use side effect was reported by a consumer or non-health professional from UNITED STATES. A 53-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Soma (dosage: NA), which was started on NS. Concurrently used drugs:
  • Pravachol
  • Prozac
  • Aspirin
  • Topamax
  • Wellbutrin
  • Lamictal
  • Seroquel Xr
  • Seroquel Xr
When starting to take Soma the consumer reported the following symptoms:
  • Off Label Use
  • Insomnia
These side effects may potentially be related to Soma.
Haematemesis, Haemoglobin Decreased, Haemorrhage, Off Label Use, Varices Oesophageal

This Off Label Use Somatuline Depot side effect was reported by a consumer or non-health professional from NETHERLANDS on Sep 22, 2010. A male , 43 years of age, was diagnosed with and was treated with Somatuline Depot. The patient presented the following health conditions:
  • Haematemesis
  • Haemoglobin Decreased
  • Haemorrhage
  • Off Label Use
  • Varices Oesophageal
. Somatuline Depot dosage: 90mg (90 Mg, 1 In 4 Wk), Intramuscular. Additional drugs used at the same time: NA. The patient was hospitalized.
Off Label Use, Renal Impairment

This is a Somatuline Depot side effect report of a 62-year-old female patient (weight:NA) from NETHERLANDS, suffering from the following symptoms/conditions: diarrhoea, who was treated with Somatuline Depot (dosage:60 Mg (60 Mg), Intramuscular, start time: Jul 09, 2010), combined with: NA., and developed a serious reaction and a Off Label Use side effect. The patient presented with:
  • Off Label Use
  • Renal Impairment
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatuline Depot treatment in female patients suffering from diarrhoea, resulting in Off Label Use.
Diarrhoea, Ileus, Off Label Use, Weight Decreased

A 70-year-old patient (weight: NA) from NETHERLANDS with the following symptoms: gastrointestinal disorder started Somatuline Depot treatment (dosage: 120 Mg, 1 In 28 D), Intramuscular) on Jun 08, 2009. Soon after starting Somatuline Depot treatment, the consumer experienced several side effects, including:
  • Diarrhoea
  • Ileus
  • Off Label Use
  • Weight Decreased
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Somatuline Depot side effects, such as Off Label Use.
Diarrhoea, Ileus, Off Label Use, Weight Decreased

A patient from NETHERLANDS was prescribed and started Somatuline Depot on Jul 13, 2010. After Soma was administered, patient encountered several Soma side effects: diarrhoea, ileus, off label use, weight decreased Additional patient health information: male , 70 years of age, The consumer reported the following symptoms: was diagnosed with and. Somatuline Depot dosage: (120 Mg,1 In 28 D),intramuscular. Concurrently used drugs: NA. The patient was hospitalized.
Gallbladder Disorder, Hepatitis Acute, Hypoglycaemia, Off Label Use

This report suggests a potential Somatuline L.p. 120mg (lanreotide Autogel) (lanreotide0 (lanreotide) Off Label Use side effect(s) that can have serious consequences. A 26-year-old female patient from FRANCE (weight:NA) was diagnosed with the following health condition(s): insulinoma and used Somatuline L.p. 120mg (lanreotide Autogel) (lanreotide0 (lanreotide) (dosage: 120 Mg (120, 1 In 28 D), Subcutaneous- 03/11/2010 Injection Delayed, Then Reduced To 60 Mg) starting Mar 11, 2010. Soon after starting Somatuline L.p. 120mg (lanreotide Autogel) (lanreotide0 (lanreotide) the patient began experiencing various side effects, including:
  • Gallbladder Disorder
  • Hepatitis Acute
  • Hypoglycaemia
  • Off Label Use
Drugs used concurrently:
  • Lamictal
  • Minidril (eugynon)
Although Somatuline L.p. 120mg (lanreotide Autogel) (lanreotide0 (lanreotide) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Off Label Use, may still occur.
Abdominal Pain, Asthenia, Chills, Diarrhoea, Malaise, Nausea, Off Label Use

An adverse event was reported by a consumer or non-health professional on May 20, 2010 by a Female taking Somatuline Autosolution 60mg (lanreotide Autogel) (lanreotide) (landro (dosage: 60 Mg (60 Mg)) was diagnosed with and. Location: NETHERLANDS , 55 years of age, patient began experiencing various side effects, including: Patient felt the following Soma side effects: abdominal pain, asthenia, chills, diarrhoea, malaise, nausea, off label use. Additional medications/treatments: The patient was hospitalized.
Diarrhoea, Off Label Use

This Off Label Use problem was reported by a consumer or non-health professional from NETHERLANDS. A 65-year-old patient (weight: NA) was diagnosed with the following medical condition(s): chronic myeloid leukaemia,metastases to liver,pancreatic carcinoma.On Jun 02, 2009 a consumer started treatment with Somatuline Depot (dosage: (,1 In 4 Wk),subcutaneous). The following drugs/medications were being taken at the same time: NA. When commencing Somatuline Depot, the patient experienced the following unwanted symptoms /side effects:
  • Diarrhoea
  • Off Label Use
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Off Label Use, may become evident only after a product is in use by the general population.
Blood Alkaline Phosphatase Increased, Off Label Use, Pancreatitis, Transaminases Increased

This is a Somatuline Depot side effect report of a 25-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: insulinoma and was treated with Somatuline Depot (dosage: 120 Mg (120 Mg, 1 In 28 D), Subcutaneous) starting May 01, 2010. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Blood Alkaline Phosphatase Increased
  • Off Label Use
  • Pancreatitis
  • Transaminases Increased
The patient was hospitalized. This opens a possibility that Somatuline Depot could cause Off Label Use and that some female patients may be more susceptible.
Anaemia, Body Mass Index Decreased, Off Label Use, Weight Decreased

This Off Label Use side effect was reported by a consumer or non-health professional from UNITED KINGDOM on Feb 22, 2010. A patient from UNITED KINGDOM , 84 years of age, weighting 123.5 lb, was diagnosed with and was treated with Somatuline Depot. Patient felt the following Soma side effects: anaemia, body mass index decreased, off label use, weight decreased. Somatuline Depot dosage: 60 Mg, 1 In 1 M), Intramuscular.
Multiple prescriptions taken:
  • Omeprazole
  • Hydroxocobalamin (hydroxocobalamin)
  • Adalat Cc
These side effects may potentially be related to Somatuline Depot.

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Soma Off Label Use Causes and Reviews


Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.

You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.

Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).

NIH: National Cancer Institute


Soma Off Label Use Reviews

Fri, 24 Feb 2012

My 19 year old son tried to give blood the other day and he was refused because he answered the question that he had taken HGH, Somatropin under a doctor's care.  He asked why and they said it had been shown to cause birth defects.  I am trying to find information on that but I am not being successful.
He took the drugs for about 5 years 12-17.  As we look to the future and him possibly having children is this something we need to be concerned about or aware of?  We are in the process of contacting the doctor who prescribed the meds to get his input.

Tue, 19 Jul 2011

Why do people die after starting Growth Hormone treatment?

Fri, 08 Jul 2011

Sorry about my poor medical english.
I am counselling as a lawyer a young man suffering from liposarcoma, we believe related to Saizen that he received during his childhood.Saizen was the french commercial name for Somatropin.
Has anyone got info on the related risk of cancer?
I would very much appreciate any help to links or info.

Mon, 19 Oct 2009
at what age will be recomended to use HGH for athlete of high level of competence..
Tue, 31 May 2011
I have been on Somatuline Depot since December 2010, I feel like a chemo patient, I have lost my hair, but not lost any weight, will I lose weight, i was 160 in january of last yeat I was 214 since surgery in November. and will I be on the Somatuline for years. is there a recovery for acromegely? I just feel lost right now
Tue, 01 Jun 2010
Somac prescribed for a hyatis hernia. Side effects include: Dizziness, skin itching amp; rash,extreme Sweating, Bloating, gas. Will stop taking medication to see if symptoms persist.
Tue, 11 Jan 2011
I've been on it for 9 months. I weighed at the beginning 125 and had a body fat of 24. I now weigh 130 I have the same body fat percentage. While I have increased muscle mass, I eat well work out, have increased cardio amp; workouts, I'm sad that the only way that I can decrease my body fat is to eat less amp; be hungry always. So of course I can get leaner but cannot stay there. Too painful. It has increased my recovery time from workouts but I'm thinking of going off of it since I am able to control my weight the same as with it or without it.. I am wondering if others do not get leaned out on his product.. I started it because I was so deficient that I had to recover for weeks most time between workouts and had trouble functioning in my. Life. So that is superior now. I thought it would help with fat loss but it does not for me
Sat, 09 Jul 2011
hi i need information toward Somatropin label price?
DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Soma Side Effects

Headache (108)
Death (106)
Nausea (95)
Diarrhoea (90)
Condition Aggravated (77)
Dyspnoea (69)
Vomiting (64)
Pituitary Tumour Benign (62)
Fatigue (61)
Abdominal Pain (59)
Craniopharyngioma (59)
Asthenia (56)
Cholelithiasis (50)
Fall (49)
Neoplasm Recurrence (48)
Injection Site Pain (46)
Arthralgia (46)
Pain (43)
Sleep Apnoea Syndrome (42)
Dizziness (39)
Depression (38)
Weight Increased (38)
Malaise (36)
Chest Pain (36)
Disease Progression (34)
Convulsion (34)
Adenoidal Hypertrophy (33)
Insomnia (33)
Neoplasm Progression (33)
Pyrexia (33)
Pneumonia (32)
Abdominal Pain Upper (31)
Rash (31)
Insulin-like Growth Factor Increased (31)
Meningioma (29)
Tonsillar Hypertrophy (29)
Weight Decreased (27)
Abdominal Distension (27)
Cerebrovascular Accident (26)
Dehydration (26)
Muscle Spasms (26)
Off Label Use (26)
Prostate Cancer (25)
Constipation (24)
Hypertension (23)
Somnolence (23)
Anxiety (22)
Injection Site Nodule (22)
Blood Glucose Increased (22)
Anaemia (21)

➢ More

Discuss Soma Side Effects